Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lucila G.G. Pacífico is active.

Publication


Featured researches published by Lucila G.G. Pacífico.


Microbial Cell Factories | 2007

Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis

Luciana Santos Cardoso; Maria Ilma Araujo; Alfredo M. Goes; Lucila G.G. Pacífico; Ricardo Riccio Oliveira; Sergio C. Oliveira

BackgroundRecombinant proteins expressed in Escherichia coli vectors are generally contaminated with endotoxin. In this study, we evaluated the ability of Polymyxin B to neutralize the effect of LPS present as contaminant on Schistosoma mansoni recombinant proteins produced in E. coli in inducing TNF-α and IL-10. Peripheral blood mononuclear cells from individuals chronically infected with S. mansoni were stimulated in vitro with recombinant Sm22.6, Sm14 and P24 antigens (10 μg/mL) in the presence of Polymyxin B (10 μg/mL).ResultsThe levels of cytokines were measured using ELISA. There was greater than 90 % reduction (p < 0.05) in the levels of TNF-α and IL-10 when Polymyxin B was added to the cultures stimulated with LPS. In cultures stimulated with S. mansoni recombinant proteins in the presence of Polymyxin B, a reduction in the levels of TNF-α and IL-10 was also observed. However, the percentage of reduction was lower when compared to the cultures stimulated with LPS, probably because these proteins are able to induce the production of these cytokines by themselves.ConclusionThis study showed that Polymyxin B was able to neutralize the effect of endotoxin, as contaminant in S. mansoni recombinant antigens produced in E. coli, in inducing TNF-α and IL-10 production.


Infection and Immunity | 2009

Schistosoma mansoni Antigens Modulate Experimental Allergic Asthma in a Murine Model: a Major Role for CD4 CD25 Foxp3 T Cells Independent of Interleukin-10

Lucila G.G. Pacífico; Fábio V. Marinho; Cristina Toscano Fonseca; Michele M. Barsante; Vanessa Pinho; Policarpo A. Sales-Junior; Luciana Santos Cardoso; Maria Ilma Araujo; Edgar M. Carvalho; Geovanni Dantas Cassali; Mauro M. Teixeira; Sergio C. Oliveira

ABSTRACT In areas where schistosomiasis is endemic, a negative correlation is observed between atopy and helminth infection, associated with a low prevalence of asthma. We investigated whether Schistosoma mansoni infection or injection of parasite eggs can modulate airway allergic inflammation in mice, examining the mechanisms of such regulation. We infected BALB/c mice with 30 S. mansoni cercariae or intraperitoneally injected 2,500 schistosome eggs, and experimental asthma was induced by ovalbumin (OVA). The number of eosinophils in bronchoalveolar lavage fluid was higher in the asthmatic group than in asthmatic mice infected with S. mansoni or treated with parasite eggs. Reduced Th2 cytokine production, characterized by lower levels of interleukin-4 (IL-4), IL-5, and immunoglobulin E, was observed in both S. mansoni-treated groups compared to the asthmatic group. There was a reduction in the number of inflammatory cells in lungs of S. mansoni-infected and egg-treated mice, demonstrating that both S. mansoni infection and the egg treatment modulated the lung inflammatory response to OVA. Only allergic animals that were treated with parasite eggs had increased numbers of CD4+ CD25+ Foxp3+ T cells and increased levels of IL-10 and decreased production of CCL2, CCL3, and CCL5 in the lungs compared to the asthmatic group. Neutralization of IL-10 receptor or depletion of CD25+ T cells in vivo confirmed the critical role of CD4+ CD25+ Foxp3+ regulatory T cells in experimental asthma modulation independent of IL-10.


Acta Tropica | 2008

Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice

Teresa C.M. Garcia; Cristina Toscano Fonseca; Lucila G.G. Pacífico; Fernanda do Valle Durães; Fábio V. Marinho; Marcos Penido; Marcelo Vidigal Caliari; Alan Lane de Melo; Hudson Alves Pinto; Michele M. Barsante; Edecio Cunha-Neto; Sergio C. Oliveira

Sm14 and paramyosin are two major Schistosoma mansoni vaccine candidate antigens. Recently, we have identified Sm14 and paramyosin epitopes that are recognized by T cells of resistant individuals living in endemic areas for schistosomiasis. Herein, mice were immunized with these peptides separately or in association in order to evaluate their vaccine potential. Immunization of mice with Sm14 peptides alone or mixed with paramyosin peptides was able to induce 26%-36.7% or 28%-29.2% of worm burden reduction, 67% or 46% of intestinal eggs reduction and also 54%-61% or 43%-52% of liver pathology reduction, respectively. Protection was associated with a Th1 type of immune response induced by Sm14 peptide immunization. In contrast, paramyosin peptide vaccination did not engender protective immunity or liver pathology reduction and immunization was associated with a Th2 type of immune response.


Memorias Do Instituto Oswaldo Cruz | 2006

Schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals

Luciana Santos Cardoso; Sergio C. Oliveira; Lucila G.G. Pacífico; Alfredo M. Goes; Ricardo Riccio Oliveira; Cristina Toscano Fonseca; Edgar M. Carvalho; Maria Ilma Araujo

UNLABELLED Asthmatics infected with Schistosoma mansoni have a less severe course of asthma and an inhibition of the Th2 inflammatory response that seems to be mediated by interleukin (IL-10). The objective of this study was to evaluate the capacity of some S. mansoni antigens to stimulate IL-10 production in vitro by cells of asthmatic infected individuals. Peripheral bloods mononuclear cells were stimulated with the S. mansoni recombinant antigens Sm22.6, Sm14, P24, and PIII antigen. IL-10 was measured in the supernatants of cultures. As the recombinant antigens were cloned in Escherichia coli, we blocked contaminant endotoxin with polymyxin B added to the cultures. We demonstrated that all antigens used drove high production of IL-10 in S. mansoni infected individuals (n = 13, 408 +/- 514 and 401 +/- 383 pg/ml, 484 +/- 245 pg/ml, 579 +/- 468 pg/ml, respectively). In asthmatics infected with S. mansoni (n = 21) rP24 induced higher levels of IL-10 (565 +/- 377 pg/ml) when compared to PIII, rSm14 and rSm22.6 (184 +/- 209 pg/ml; 292 +/- 243 pg/ml; 156 +/- 247 pg/ml, respectively). CONCLUSION the S. mansoni antigens evaluated in this study stimulated IL-10 production by cells from infected individuals and therefore they have the potential to be used as a modulator of the inflammatory response in asthma.


PLOS ONE | 2013

Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk Proteins

Andrés E. Ibañez; Paola Smaldini; Lorena M. Coria; María Victoria Delpino; Lucila G.G. Pacífico; Sergio C. Oliveira; Gabriela Sofía Risso; Karina A. Pasquevich; Carlos A. Fossati; Guillermo H. Giambartolomei; Guillermo H. Docena; Juliana Cassataro

The discovery of novel mucosal adjuvants will help to develop new formulations to control infectious and allergic diseases. In this work we demonstrate that U-Omp16 from Brucella spp. delivered by the nasal route (i.n.) induced an inflammatory immune response in bronchoalveolar lavage (BAL) and lung tissues. Nasal co-administration of U-Omp16 with the model antigen (Ag) ovalbumin (OVA) increased the amount of Ag in lung tissues and induced OVA-specific systemic IgG and T helper (Th) 1 immune responses. The usefulness of U-Omp16 was also assessed in a mouse model of food allergy. U-Omp16 i.n. administration during sensitization ameliorated the hypersensitivity responses of sensitized mice upon oral exposure to Cow’s Milk Protein (CMP), decreased clinical signs, reduced anti-CMP IgE serum antibodies and modulated the Th2 response in favor of Th1 immunity. Thus, U-Omp16 could be used as a broad Th1 mucosal adjuvant for different Ag formulations.


Memorias Do Instituto Oswaldo Cruz | 2011

Identification of Schistosoma mansoni candidate antigens for diagnosis of schistosomiasis

Gardênia Braz Figueiredo de Carvalho; Rosiane A. Silva-Pereira; Lucila G.G. Pacífico; Cristina Toscano Fonseca

The development of a more sensitive diagnostic test for schistosomiasis is needed to overcome the limitations of the use of stool examination in low endemic areas. Using parasite antigens in enzyme linked immunosorbent assay is a promising strategy, however a more rational selection of parasite antigens is necessary. In this study we performed in silico analysis of the Schistosoma mansoni genome, using SchistoDB database and bioinformatic tools for screening immunogenic antigens. Based on evidence of expression in all parasite life stage within the definitive host, extracellular or plasmatic membrane localization, low similarity to human and other helminthic proteins and presence of predicted B cell epitopes, six candidates were selected: a glycosylphosphatidylinositol-anchored 200 kDa protein, two putative cytochrome oxidase subunits, two expressed proteins and one hypothetical protein. The recognition in unidimensional and bidimensional Western blot of protein with similar molecular weight and isoelectric point to the selected antigens by sera from S. mansoni infected mice indicate a good correlation between these two approaches in selecting immunogenic proteins.


Memorias Do Instituto Oswaldo Cruz | 2006

Aluminum hydroxide associated to Schistosoma mansoni 22.6 kDa protein abrogates partial protection against experimental infection but not alter interleukin-10 production

Lucila G.G. Pacífico; Cristina Toscano Fonseca; Michele M. Barsante; Luciana Santos Cardoso; Maria Ilma Araujo; Sergio C. Oliveira

The need to develop a vaccine against schistosomiasis led several researches and our group to investigate proteins from Schistosoma mansoni as vaccine candidates. Sm22.6 is a protein from S. mansoni that shows high identity with Sj22.6 and Sh22.6 (79 and 91%, respectively). These proteins are associated with high levels of IgE and protection to reinfection. Previously, we have shown that Sm22.6 induced a partial protection of 34.5% when used together with Freunds adjuvant and produced a Th0 type of immune response with interferon-g and interleukin-4. In this work, mice were immunized with Sm22.6 alone or with aluminum hydroxide adjuvant and high levels of IgG, IgG1, and IgG2a were measured. Unfortunately, no protection was detected. Since IL-10 is a modulating cytokine in schistosomiasis, we also observed a high level of this molecule in splenocytes of vaccinated mice. In conclusion, we did not observe the adjuvant effect of aluminum hydroxide associated with rSm22.6 in protective immunity.


Genetics and Molecular Biology | 2004

Clustering and artificial neural networks: classification of variable lengths of Helminth antigens in set of domains

Thiago S. Rodrigues; Lucila G.G. Pacífico; Santuza M. R. Teixeira; Sergio C. Oliveira; Antônio de Pádua Braga

A new scheme for representing proteins of different lengths in number of amino acids that can be presented to a fixed number of inputs Artificial Neural Networks (ANNs) speel-out classification is described. K-Meanss clustering of the new vectors with subsequent classification was then possible with the dimension reduction technique Principal Component Analysis applied previously. The new representation scheme was applied to a set of 112 antigens sequences from several parasitic helminths, selected in the National Center for Biotechnology Information and classified into fourth different groups. This bioinformatic tool permitted the establishment of a good correlation with domains that are already well characterized, regardless of the differences between the sequences that were confirmed by the PFAM database. Additionally, sequences were grouped according to their similarity, confirmed by hierarchical clustering using ClustalW.


Immunobiology | 2006

Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine

Lucila G.G. Pacífico; Cristina Toscano Fonseca; Lucimara Chiari; Sergio C. Oliveira


Microbes and Infection | 2006

Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.

Cristina Toscano Fonseca; Lucila G.G. Pacífico; Michele M. Barsante; Tatiana Rassi; Geovanni Dantas Cassali; Sergio C. Oliveira

Collaboration


Dive into the Lucila G.G. Pacífico's collaboration.

Top Co-Authors

Avatar

Sergio C. Oliveira

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Cristina Toscano Fonseca

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maria Ilma Araujo

Federal University of Bahia

View shared research outputs
Top Co-Authors

Avatar

Michele M. Barsante

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Alfredo M. Goes

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Antônio de Pádua Braga

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Edgar M. Carvalho

Federal University of Bahia

View shared research outputs
Top Co-Authors

Avatar

Fábio V. Marinho

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Geovanni Dantas Cassali

Universidade Federal de Minas Gerais

View shared research outputs
Researchain Logo
Decentralizing Knowledge